Literature DB >> 403869

Role of glucagon in diabetes.

R H Unger, L Orci.   

Abstract

The glucagon-secreting A cell is a vital component of the organ system which regulates the distribution of fuel--the islets of Langerhans. Bihormonal control of glucoregulation through a push-pull system maintains the glucose concentration of extracellular fluid within narrow limits irrespective of glucose flux rates through relative equality of glucose influx and efflux. This equality requires appropriate secretion mixtures of the biologic antagonists, insulin and glucagon, directed by a glucose sensor. In severe diabetes, there are virtually no B cells and A cells are in contact largely with other A cells and their glucose-sensing capacity is lost. The A cell hypersecretes and in most juvenile type diabetics aggressive therapy with insulin fails to restore it to normal. Glucagon is a factor in the development of endogenous hyperglycemia, and ketoacidosis. Its suppression may provide a possible approach in the future pharmacologic management of diabetic hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403869

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

1.  Different susceptibility of rat pancreatic alpha and beta cells to hypoxia.

Authors:  Konstantin Bloch; Julia Vennäng; Daniel Lazard; Pnina Vardi
Journal:  Histochem Cell Biol       Date:  2012-02-05       Impact factor: 4.304

2.  An overview of glucagon research.

Authors:  Isabel Valverde
Journal:  Diabetologia       Date:  2016-04-26       Impact factor: 10.122

3.  The value of good control.

Authors:  J C Pickup; H Keen
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

Review 4.  The physiology of glucagon.

Authors:  Gerald J Taborsky
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 5.  Continuous subcutaneous insulin infusion: a developing tool in diabetes research.

Authors:  J C Pickup; H Keen
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

6.  Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog.

Authors:  R W Stevenson; P E Williams; A D Cherrington
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

7.  The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.

Authors:  K Pilgaard; C B Jensen; J H Schou; V Lyssenko; L Wegner; C Brøns; T Vilsbøll; T Hansen; S Madsbad; J J Holst; A Vølund; P Poulsen; L Groop; O Pedersen; A A Vaag
Journal:  Diabetologia       Date:  2009-03-14       Impact factor: 10.122

8.  Chemically induced (streptozotocin-alloxan) diabetes mellitus in the dog. Biochemical and ultrastructural studies.

Authors:  H E Black; I Y Rosenblum; C C Capen
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

9.  Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.

Authors:  S Del Prato; F Riva; A Devidé; R Nosadini; D Fedele; A Tiengo
Journal:  Acta Diabetol Lat       Date:  1980 Apr-Jun

10.  Alterations in islet cell ultrastructure following streptozotocin-induced diabetes in the rat.

Authors:  H E Gruber; H P Schedl; J W Osborne
Journal:  Acta Diabetol Lat       Date:  1980 Jul-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.